NasdaqGS - Delayed Quote
USD
Latigo Biotherapeutics, Inc. (LTGO)
13.35
+0.75
(+5.95%)
At close: 4:00:01 PM EST
13.35
0.00
(0.00%)
After hours: 4:00:23 PM EST
Earnings Trends
Earnings Per Share (GAAP)
Revenue vs. Earnings
Q3 FY26
Revenue
--
Earnings
-20.95M
Profit Margin
0.00%
Q2
FY26
Q3
FY26
-25M
-20M
-15M
-10M
-5M
0
0.0%
Revenue Estimate
| Currency in USD
|
Current Qtr. (Dec 2026)
|
Next Qtr. (Mar 2027)
|
Current Year (2026)
|
Next Year (2027)
|
|---|---|---|---|---|
|
No. of Analysts
|
4 | 3 | 4 | 4 |
|
Avg. Estimate
|
-- | -- | -- | -- |
|
Low Estimate
|
-- | -- | -- | -- |
|
High Estimate
|
-- | -- | -- | -- |
|
Year Ago Sales
|
-- | -- | -- | -- |
|
Sales Growth (year/est)
|
-- | -- | -- | 0.00% |
Earnings Estimate
| Currency in USD
|
Current Qtr. (Dec 2026)
|
Next Qtr. (Mar 2027)
|
Current Year (2026)
|
Next Year (2027)
|
|---|---|---|---|---|
|
No. of Analysts
|
-- | -- | -- | -- |
|
Avg. Estimate
|
-- | -- | -- | -- |
|
Low Estimate
|
-- | -- | -- | -- |
|
High Estimate
|
-- | -- | -- | -- |
|
Year Ago EPS
|
-- | -- | -- | -- |
Earnings History
EPS Trend
| Currency in USD
|
Current Qtr. (Dec 2026)
|
Next Qtr. (Mar 2027)
|
Current Year (2026)
|
Next Year (2027)
|
|---|---|---|---|---|
|
Current Estimate
|
-- | -- | -- | -- |
|
7 Days Ago
|
-- | -- | -- | -- |
|
30 Days Ago
|
-- | -- | -- | -- |
|
60 Days Ago
|
-- | -- | -- | -- |
|
90 Days Ago
|
-- | -- | -- | -- |
EPS Revisions
| Currency in USD
|
Current Qtr. (Dec 2026)
|
Next Qtr. (Mar 2027)
|
Current Year (2026)
|
Next Year (2027)
|
|---|---|---|---|---|
|
Up Last 7 Days
|
-- | -- | -- | -- |
|
Up Last 30 Days
|
-- | -- | -- | -- |
|
Down Last 7 Days
|
-- | -- | -- | -- |
|
Down Last 30 Days
|
-- | -- | -- | -- |
Growth Estimates
| Symbol | Current Qtr. | Next Qtr. | Current Year | Next Year |
|---|---|---|---|---|
|
LTGO
|
-- | -- | -- | -- |
|
S&P 500
|
28.96% | 27.13% | 33.26% | 16.73% |
